Scott Wolchko | President and CEO |
Ed Dulac | CFO |
Yu-Waye Chu | Chief Medical Officer |
Tazeen Ahmad | Bank of America |
Kelsey Goodwin | Guggenheim Securities |
Tyler Van Buren | Cowen |
Ashiq Mubarack | Citigroup |
Michael Yee | Jefferies |
James Shin | Abbott |
Matt Biegler | Oppenheimer |
Daina Graybosch | SVB Securities |
Robyn Kay Karnauskas | Truist Securities |
Welcome to the Fate Therapeutics Second Quarter 2022 Financial Results Conference Call. [Operator Instructions] As a reminder, today's call is being recorded. I would now like to introduce Scott Wolchko, President and CEO of Fate Therapeutics.
Thank you. Good afternoon, and thanks, everyone, for joining us for the Fate Therapeutics Second Quarter 2022 Financial Results Call.